Table 3.
The number and percentage of papers that included dose-response data for each immunological response type.
| Number of Papers (%) | Response Type | Paper References |
|---|---|---|
| 18 (51%) | Antibody | [16,17,20,21,22,23,25,26,27,28,31,33,36,39,40,42,45,48] |
| 12 (34%) | T cell count | [16,20,21,26,27,28,30,32,36,38,42,47] |
| 12 (34%) | CD8+ T cell count | [19,22,24,32,34,35,36,38,39,48,49,50] |
| 11 (31%) | Virus Neutralisation Titre | [22,25,27,29,30,34,36,37,43,44,46] |
| 4 (12%) | CD4+ T cell count | [19,32,35,38] |
| 3 (9%) | CD8+ T Cell, IFN-y+ Percentage | [19,21,41] |
| 3 (9%) | CD4+ T Cell, IFN-y+ Percentage | [19,21] |
| 2 (6%) | CD4+ T Cell, TNF-a+ Percentage | [19,21] |
| 2 (6%) | CD8+ T Cell, TNF-a+ Percentage | [21] |
| 2 (6%) | CD4+ T Cell, IL-2+ Percentage | [19,21] |
| 2 (6%) | CD8+ T Cell, Il-2+ Percentage | [21] |
| 1 (3%) | CD4+ T Cell, Il-17+ Percentage | [19] |